research peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-02-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
These higher frequencies permit the great bandwidth required for television broadcasting. Since natural and artificial noise sources are less present at these frequencies, high-quality audio transmission is possible, using frequency modulation.
positive supercoiling The supercoiling of a double-stranded DNA molecule in the same direction as the turn of the double helix itself (e.g. a right-handed coiling of a helix with a right-handed turn). Contrast negative supercoiling.
=== Hydration and related reactions of acetylene === Several Hg-catalyzed conversions of acetylene have been commercialized by Hoechst AG, BASF, and Chisso. Acetaldehyde is produced by Hg-catalyzed hydration of acetylene:
Sources: en.wikipedia.org
== Usage during original Cold War == The phrase "new Cold War" was first used in 1955 by US secretary of state John Foster Dulles, and in a 1956 New York Times article warning of Soviet propaganda promoting the Cold War's resurgence. Other analysts, such as academics Fred Halliday, Alan M. Wald, David S. Painter, and Noam Chomsky, used the interchangeable terms to refer to the 1979–1985 or 1985–1991 phases of the Cold War. Some other analysts used similar terms to refer to the Cold War of the mid-1970s. Columnist William Safire argued in a 1975 New York Times editorial that the Nixon administration's policy of détente with the Soviet Union had failed and that "Cold War II" was then underway. Academic Gordon H. Chang used the term "Cold War II" to refer to the Cold War period after the 1972 meeting in China between US president Richard Nixon and Chinese Communist Party chairman Mao Zedong.
Sarah and Mark meet and talk on friendly terms at various times thereafter. Gaby (Minka Kelly) was Max's behavioral aide. Kristina is initially threatened by Gaby's ability to get through to Max. However, Kristina eventually confides in Gaby after having a breakdown. Adam finds Gaby partying at a Mexican restaurant and taking many shots of tequila; he is amazed that Gaby shows up to work the next day without a hair out of place. She befriends Crosby, and ends up sleeping with him; in the aftermath, she quits her job as Max's behavioral aide. However, she comes back to talk to Kristina about helping Max, where the two women aren't exactly friendly but do part on civil terms. Steve Williams (Asher Book) was Haddie's boyfriend, but Haddie broke up with him because she didn't want to sleep with him. His affections for Amber afterward cause tensions between Amber and Haddie (who get in a fight) and other members of the family. His dad has MS, and he confides in Amber for the first time about his father's condition. He reveals to Amber's mother and uncle his love for Amber after she runs away. Renee Trussell (Tina Lifford) is Jasmine's mother and Jabbar's (and baby Aida's) grandmother. Jabbar stays with Renee while Jasmine is performing with the dancing troupe. She is very cold and mean towards Crosby and doesn't think he can live up to his promises. Crosby retaliates by telling her that he is not a pushover and that he will be for Jasmine and Jabbar. Renee smiles and congratulates Crosby on his mature behavior.
== Scope == EARS-Net tracks resistance rates reported in routine clinical antimicrobial susceptibility data from local and clinical laboratories, gathered by national surveillance programs and laboratory networks. Resistance status is determined according to EUCAST guidelines. Only data from invasive isolates (blood and cerebrospinal fluid) are included in EARS-Net. The antibiotics for which resistance is tracked varies by species, and is based on EUCAST recommendations. Resistance data is collected for these eight pathogens only:
==== Sigma bond cleavage / σ-cleavage ==== Sigma bond cleavage is most commonly observed in molecules that can produce stable cations, such as saturated alkanes or secondary and tertiary carbocations. This occurs when an alpha electron is removed. The C-C bond elongates and weakens causing fragmentation. Fragmentation at this site produces a charged and a radical fragment.
Sources: en.wikipedia.org
Hardwood lumber kiln drying schedules typically keep the dry bulb temperature below 80 °C (176 °F). Difficult-to-dry species might not exceed 60 °C (140 °F). Dehumidification kilns are very similar to conventional kilns in basic construction. Drying times are usually comparable. Heat is primarily supplied by an integral dehumidification unit which also serves to remove humidity. Auxiliary heat is often provided early in the schedule where the heat required may exceed the heat generated by the DH unit. Solar kilns are conventional kilns, typically built by hobbyists to keep initial investment costs low. Heat is provided via solar radiation, while internal air circulation is typically passive. In 1949 a Chicago company introduced a wood drying kiln that used infrared lamps that they claimed reduced the standard drying time from 14 days to 45 minutes. Newer wood drying technologies have included the use of reduced atmospheric pressure to attempt to speed up the drying process. A variety of vacuum technologies exist, varying primarily in the method heat is introduced into the wood charge. Hot water platten vacuum kilns use aluminum heating plates with the water circulating within as the heat source, and typically operate at significantly reduced absolute pressure. Discontinuous and SSV (super-heated steam) use atmosphere to introduce heat into the kiln charge. Discontinuous technology allows the entire kiln charge to come up to full atmospheric pressure, the air in the chamber is then heated, and finally vacuum is pulled.
=== Incandescent lamps === 'Black light' incandescent lamps are also made from an incandescent light bulb with a filter coating which absorbs most visible light. Halogen lamps with fused quartz envelopes are used as inexpensive UV light sources in the near UV range, from 400 to 300 nm, in some scientific instruments. Due to its black-body spectrum a filament light bulb is a very inefficient ultraviolet source, emitting only a fraction of a percent of its energy as UV, as explained by the black body spectrum.
=== Evolution === Virtually all vertebrates have an oxytocin-like nonapeptide hormone that supports reproductive functions and a vasopressin-like nonapeptide hormone involved in water regulation. The two genes are usually located close to each other (fewer than 15,000 bases apart) on the same chromosome. They are transcribed in opposite directions (however, in fugu, the homologs are further apart and transcribed in the same direction). The two genes are believed to result from a gene duplication event; the ancestral gene is estimated to be about 500 million years old and is found in cyclostomata (modern members of the Agnatha). A 2023 study found that zebrafish utilize oxytocin in reaction to the fear of other fish. It found that zebrafish oxytocin production, removed by gene editing, cannot respond to the fear of other fish. When oxytocin is injected back into the fish, they react again, suggesting they may have empathy regarding this emotion. Furthermore, because the same brain regions are involved as in mammals, the study suggests oxytocin-based empathy may have evolved from a common ancestor many millions of years ago.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.